Guangdong Fangshengrong Pharmaceutical

Guangdong Fangshengrong Pharmaceutical is a Chinese pharmaceutical company focused on the research, development, and large-scale manufacturing of high-quality chemical drugs. A subsidiary of the publicly traded Hunan Fangsheng Pharmaceutical, the company operates a significant production base in Huizhou, Guangdong, specializing in digestive system treatments and cardiovascular health. Its core product portfolio includes proton pump inhibitors such as Ilaprazole, which are used to treat acid-related gastrointestinal disorders. The company maintains modern GMP-certified facilities and integrates R&D with industrial-scale production to serve both domestic and international markets.